EX-2.1 2 e5418_ex2-1.htm EXHIBIT 2.1

 

 

 

EXHIBIT 2.1

 

SECOND AMENDMENT TO Stock Purchase Agreement

 

This Second Amendment (this “Amendment”) to the Stock Purchase Agreement, dated as of September 28, 2023 (the “Agreement”), by and among Renovaro Biosciences Inc., a Delaware corporation (“Buyer”), Gedi Cube Intl Ltd., a private limited company incorporated under the laws of England and Wales (“Company”), each of the shareholders of the Company signatory thereto (collectively, the “Sellers”) and Yalla Yalla Ltd., a private limited liability company registered and incorporated under the laws of Malta with company registration number C 103531, in its capacity as representative to the Sellers, is dated February 9, 2024. Capitalized terms used herein, which are not otherwise defined herein, shall have the meanings assigned to such terms in the Agreement.

 

WHEREAS, the undersigned desire to amend the Agreement pursuant to the terms of and subject to the conditions set forth in this Amendment; and

 

Whereas, pursuant to Section 11.8 of the Agreement, the Agreement may be amended or modified by the Parties before the Closing Date, if the amendment or modification is in writing and signed on behalf of each of the Parties to the Agreement.

 

NOW, THEREFORE, in consideration of the premises set forth above and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

1.        Recitals. The foregoing recitals are hereby incorporated herein to the same extent as if hereinafter fully set forth in herein.

 

2.        Amendment Regarding Post-Closing Board. Section 2.2 of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“Post-Closing Board of Directors. The Parties shall take all necessary action, including causing certain directors of Buyer to resign, so that effective as of the Closing, Buyer’s board of directors (the “Post-Closing Buyer Board”) will consist of ten (10) individuals (such persons, the “Directors”): (i) one (1) of which shall be the Chief Executive Officer of Buyer, (ii) the five (5) persons that are designated by Buyer prior to the Closing, at least four (4) of whom shall qualify as an “independent director” under NASDAQ Listing Rule 5605(a), and (iii) the four (4) persons that are designated by Company prior to the Closing, at least two (2) of whom shall be required to qualify as an “independent director” under NASDAQ Listing Rule 5605(a); provided that the Post-Closing Buyer Board will meet all diversity and other requirements under applicable Law and the NASDAQ Listing Rules. The board of directors of Company immediately after the Closing shall be the same as the Post-Closing Buyer Board. At or prior to the Closing, Buyer will provide each Director with a customary director indemnification agreement, in form and substance reasonably acceptable to such Director, to be effective upon the Closing (or if later, such Director’s appointment).”

 

3.        No Other Amendment. Except as specifically amended by the terms herein agreed to by the Parties, the Agreement, and all other provisions thereof, shall be unchanged and shall remain in full force and effect.

 

4.        Miscellaneous. The provisions of Sections 11.1, 11.3 to 11.13, and 11.15 of the Agreement are hereby incorporated into this Amendment as if fully set forth herein and each reference to “Agreement” therein shall be deemed a reference to this Amendment.

 

[Remainder of Page Intentionally Left Blank;  

Signature Pages Follow]

 

1
 

 

IN WITNESS WHEREOF, the undersigned, intending to be legally bound hereby, have duly executed this Amendment as of the date first above written.

 

Buyer:  
   
RENOVARO BIOSCIENCES INC.  
   
By: /s/ Mark Dybul  
Name: Mark Dybul  
Title: Chief Executive Officer  

 

Company:  
   
Gedi Cube Intl LTD.  
   
By: /s/ Karen Brink  
Name: Karen Brink  
Title: Director  

 

Sellers’ Representative:  
   
Yalla Yalla LTD.  
   
By: /s/ Matthijs van Kranenburg  
Name: Matthijs van Kranenburg  
Title: Director  

 

Sellers:  
   
SEPA BEHEER BV  
   
By: /s/ Frank van Asch  
Name: F.Y. Van Asch  
Title: Director  

 

CK VA KALKEN BEHEER BV  
   
By: /s/ Coen van Kalken  
Name: CK van Kalken  
Title: Director  

 

DMZ INVEST i APS  
   
By: /s/ Flemming Segerlund  
Name: Flemming Segerlund  
Title: CEO  

 

TAEJ HOLDING B.V.  
   
By: /s/ Thomas Abeel  
Name: Thomas Abeel  
Title: Director  

 

2
 

 

Yalla Yalla LTD.  
   
By: /s/ Matthijs van Kranenburg  
Name: Matthijs van Kranenburg  
Title: Director  

 

MEDSEEK LIMITED  
   
By: /s/ Matthijs van Kranenburg  
Name: Matthijs van Kranenburg  
Title: Director  

 

SEA SIDE SEAMED LIMITED  
   
By: /s/ Matthijs van Kranenburg  
Name: Matthijs van Kranenburg  
Title: Director  

 

LAKSYA VENTURES, INC.  
   
By: /s/ Neil Persh  
Name: Neil Persh  
Title: President  

 

ALBERTUS CORNELIS MARIA PIJNENBERG  
   
By: /s/ Albertus Cornelis Maria Pijenberg  
Name: Albertus Cornelis Maria Pijenberg  

 

ANTONIUS DENIS JORIS GABRIEL VAN DAM  
   
By: /s/ Antonius Denis Jorgis Gabriel van Dam  
Name: Borko Milojkovic  

 

BORKO MILOJKOVIC  
   
By: /s/ S.B. Gleeson  
Name: Antonius Denis Jorgis Gabriel van Dam  

 

BRIAN ERASMUS LIMITED  
 
By: /s/ Borko Milojkovic  
Name: S.B. Gleeson  
Title: Director  

 

3